Biogen Idec, Inc. (Massachusetts) (BIIB) Reports Another Tysabri Brain Disease Case  
10/30/2008 6:50:37 AM

LOS ANGELES, Oct 29 (Reuters) - Biogen Idec Inc said on Wednesday that it has notified regulators of a new case of a potentially deadly brain disease in a multiple sclerosis patient being treated with Tysabri in the United States.